A NYC based anesthesiologist seemed to have passed on the hepatitis C infection to his patients. US Health Department is investigating a cluster of 3 new hepatitis C infections in people who received intravenous (IV) anesthesia from the same NYC-based anesthesiologist in August 2006.
The targeted use of an anti-estrogen drug could prolong the life of some ovarian cancer patients by up to three years, and delay the use of chemotherapy in others, revealed by researchers at the University of Edinburgh.
Genes account for only 2.5 percent of DNA in the human genetic blueprint, yet diseases can result not only from mutant genes, but from mutations of other DNA that controls genes. University of Utah researchers report in the journal Nature Genetics that they have developed a faster, less expensive technique for mutating those large, non-gene stretches of DNA.
Efforts to contain the outbreak of viral fever in Kerala intensified with defence medical teams stepping in to help the state health authorities and medicines and preventive kits being flown in to the state from the Army Depot in Mumbai.
The rights of patients and the public will be strengthened by new amendments to the Mental Health Bill published by the UK Government.
The British Association of Aesthetic Plastic Surgeons (www.baaps.org.uk), the not-for-profit organisation established for the advancement of education and practice of Aesthetic Plastic Surgery for public benefit, denounced a website offering free breast augmentations as ?degrading? and warned British women that the process was entirely inappropriate for what should be a life-changing decision.
A gene responsible for the single most common cause of hearing loss among white adults, otosclerosis, has been identified for the first time, a scientist told the annual conference of the European Society of Human Genetics in Nice, France. Melissa Thys, from the Department of Medical Genetics, University of Antwerp, Belgium, said that this finding may be a step towards new treatments for otosclerosis, which affects approximately one in 250 people.
The Department of Health today announced extra help for the NHS in tackling the spread of TB. From today, NHS commissioners will be able to access on-line the Department’s ‘TB Toolkit’.
Alli is the only FDA-approved weight-loss product available to overweight adults, 18 years or older, without a prescription. It combines a clinically-proven product with a comprehensive individualized action plan.
Results of the Option (TOcilizumab Pivotal Trial in Methotrexate Inadequate respONders) trial, the first multinational Phase III study outside of Japan, showed that patients treated with Actemra (either 4mg/kg or 8mg/kg) plus methotrexate achieved a significant and clinically important improvement in the signs and symptoms of moderate to severe rheumatoid arthritis (RA) compared to patients treated with placebo and methotrexate, a current standard of care.